ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
37 announcements with these filters
Torrent Pharmaceuticals submitted its Annual Secretarial Compliance Report for the financial year 2025-26. The report confirms full adherence to SEBI listing regulations and statutory provisions.
Torrent Pharma delivered strong Q4 growth led by India and Brazil, while successfully integrating Curatio and JB Pharma assets.
Torrent Pharmaceuticals confirmed full utilization of ₹10,990 Crore raised via NCDs for acquiring J.B. Chemicals shares. No deviations occurred during the quarter ended March 2026.
Torrent Pharmaceuticals Limited filed its security cover certificate for outstanding NCDs totaling ₹11,156.14 Crore. The filing confirms adequate asset coverage as of March 2026.
Torrent Pharmaceuticals fixed May 29, 2026, as the record date for final dividend eligibility. Shareholders must hold stock by this date to receive the payment.
Torrent Pharmaceuticals Ltd reported revenue from operations of ₹4,197 Cr (+41.8% YoY) and net profit of ₹364 Cr (-26.9% YoY) for Q4 FY26.
Torrent Pharma reported annual consolidated revenues of ₹13,980 Crore. The board recommended a ₹9 final dividend and approved a ₹5,000 Crore enabling fundraise via QIP.